ITGB1 and neoplasm: MK-expressing tumor cells are found to interact with 7 known receptors, including SDC1, SDC4, PTPRZ1, LRP-1, and the integrin family (ITGA4-ITGB1 and ITGA6-ITGB1) as well as NCL.